Schizophrenia and Related Disorders Clinical Trial
Official title:
Mechanistic Clinical Trial of Individualized tDCS for Hallucinations in Schizophrenia
This project compares standard tDCS to individualized high-definition tDCS (HD-tDCS) for treatment of auditory verbal hallucinations in schizophrenia.
The large majority of patients with schizophrenia (Sz) experience auditory verbal hallucinations (AVH) as a core feature of their disorder. Treatment-resistant auditory verbal hallucinations (AVH) affect a third of patients with schizophrenia and can cause increased aggression, distress, suicide, and social dysfunction. This project will investigate the efficacy of different types of transcranial direct current stimulation (tDCS), a neurostimulation technique that passes a weak electric current through the brain, in alleviating AVH in Sz patients, and will explore hypotheses regarding brain circuits involved in AVH. This project compares standard tDCS to individualized high-definition tDCS (HD-tDCS) for treatment of AVH. In standard tDCS, two large electrodes are positioned on the scalp above regions of the brain implicated in abnormal cortical activity associated with auditory verbal hallucinations in Sz. Due to the size of standard tDCS electrodes and the positions required to stimulate language areas, large unrelated areas of the brain are also stimulated. HD-tDCS is a novel technique that uses multiple smaller electrodes to produce a more focal electrical field (EF) than standard tDCS. The HD-tDCS used in this study modulates brain activity in a targeted area without stimulating as many unrelated areas. This targeted inhibition allows us to test hypotheses regarding different cortical regions and their roles in specific features of AVH (e.g. loudness and salience). Participants are randomized to receive either active standard tDCS or active HD-tDCS targeting one of two language-processing areas of the brain, or a sham version of one of these stimulation types. For each participant receiving HD-tDCS, structural MRI is used to computationally model the electrical field produced in their individual brain anatomy by tDCS. These models are then used to select individualized electrode configurations and current settings to target the same language areas across subjects. The effect of stimulation on relevant brain functions is verified by measuring pre/post treatment changes in resting state functional connectivity (rsFC) within and between targeted language regions, which has been previously linked to AVH symptoms. Differences in behavioral task performance and neurophysiological abnormalities associated with AVH are also tested pre/post treatment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05083377 -
Clozapine Use Pattern in the Province of Seville
|
||
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Recruiting |
NCT06134661 -
Accelerated rTMS for Psychomotor Slowing
|
N/A | |
Completed |
NCT01433094 -
Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia
|
N/A | |
Terminated |
NCT05526833 -
An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study
|
N/A | |
Recruiting |
NCT05982158 -
Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices
|
N/A | |
Active, not recruiting |
NCT06175559 -
Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia
|
N/A | |
Active, not recruiting |
NCT05673941 -
"InMotion" - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia
|
N/A | |
Recruiting |
NCT02916810 -
TMS for Symptom Reduction in Schizophrenia
|
N/A | |
Recruiting |
NCT05958875 -
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
|
Phase 4 | |
Recruiting |
NCT03525054 -
Semantic and Syntactic Computerized Analysis of Free Speech
|
||
Recruiting |
NCT05389345 -
tDCS and Executive Function Training for Schizophrenia
|
N/A | |
Completed |
NCT05601050 -
Linguistic Predictors of Outcomes in Psychosis
|
||
Completed |
NCT03075202 -
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
|
||
Completed |
NCT03921450 -
Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)
|
N/A | |
Completed |
NCT06231407 -
Increasing Medication Check Participation Through Applying CT-r
|
N/A | |
Recruiting |
NCT04478838 -
"Extended" (Alternate Day) Antipsychotic Dosing
|
Phase 4 | |
Completed |
NCT04366401 -
Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders
|
N/A | |
Completed |
NCT04612777 -
A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses
|
N/A | |
Not yet recruiting |
NCT06191965 -
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
|
Phase 2/Phase 3 |